Which of the following is a potential cause of rhabdomyolysis?

Which of the following is a potential cause of rhabdomyolysis?

• A. Antibiotics
• B. Statins
• C. ACE inhibitors
• D. Nitrates

Answer: (B)

Rhabdomyolysis is a serious condition characterized by the breakdown of muscle tissue, leading to the release of muscle fibers and proteins (like myoglobin) into the bloodstream. This can potentially result in kidney damage and other complications. Statins, commonly prescribed for lowering cholesterol levels, are known to be associated with rhabdomyolysis, especially at higher doses or in individuals with certain risk factors. The mechanism by which statins can lead to rhabdomyolysis involves muscle toxicity due to the interference with cholesterol synthesis and subsequent disturbances in muscle cell metabolism. Genetic predispositions, interactions with other medications, and underlying health conditions may further elevate the risk of muscle-related adverse effects in patients taking statins. Antibiotics, ACE inhibitors, and nitrates, while they may have their own side effects, are not commonly directly linked to the occurrence of rhabdomyolysis to the same extent as statins. In contrast, certain antibiotics, like daptomycin, can also cause muscle toxicity, but this is not a general characteristic of all antibiotics. ACE inhibitors and nitrates are primarily associated with effects on blood pressure and cardiovascular function, rather than muscle breakdown. Thus, of the options provided, statins stand out as

Rhabdomyolysis is a serious condition characterized by the breakdown of muscle tissue, leading to the release of muscle fibers and proteins (like myoglobin) into the bloodstream. This can potentially result in kidney damage and other complications. Statins, commonly prescribed for lowering cholesterol levels, are known to be associated with rhabdomyolysis, especially at higher doses or in individuals with certain risk factors.

The mechanism by which statins can lead to rhabdomyolysis involves muscle toxicity due to the interference with cholesterol synthesis and subsequent disturbances in muscle cell metabolism. Genetic predispositions, interactions with other medications, and underlying health conditions may further elevate the risk of muscle-related adverse effects in patients taking statins.

Antibiotics, ACE inhibitors, and nitrates, while they may have their own side effects, are not commonly directly linked to the occurrence of rhabdomyolysis to the same extent as statins. In contrast, certain antibiotics, like daptomycin, can also cause muscle toxicity, but this is not a general characteristic of all antibiotics. ACE inhibitors and nitrates are primarily associated with effects on blood pressure and cardiovascular function, rather than muscle breakdown. Thus, of the options provided, statins stand out as